Association of E/E′ and NT-proBNP with Renal Function in Patients with Essential Hypertension

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Yang, Yan ^a   Wang, Yan ^a   Shi, Zhong Wei ^a   Zhu, Ding Liang ^a,b   Gao, Ping Jin ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Chinese Academy of Sciences   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGE DISTRIBUTION; ALBUMINURIA; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; CREATININE URINE LEVEL; DECELERATION; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; GLOMERULUS FILTRATION RATE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FUNCTION; HUMAN; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TISSUE DOPPLER IMAGING;

ADULT; DIASTOLE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84873842935     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054513     Document Type: Article

References (44)

1. Khan NA, Ma I, Thompson CR, Humphries K, Salem DN, et al. (2006) Kidney function and mortality among patients with left ventricular systolic function. J Am Soc Nephrol 17: 244-253.
2. McAlister FA, Ezkowitz J, Tonelli M, Armstrong PW, (2004) Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 109: 1004-1009.
3. Nardi E, Palermo A, Mulè G, Cusimano P, Cottone S, et al. (2009) Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease. J Hypertens 27: 633-641.
4. Nardi E, Cottone S, Mulè G, Palermo A, Cusimano P, et al. (2007) Influence of chronic renal insufficiency on left ventricular diastolic function in hypertensives without left ventricular hypertrophy. J Nephrol 20: 320-328.
5. Bella JN, Palmieri V, Roman MJ, Liu JE, Welty TK, et al. (2002) Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study. Circulation 105: 1928-1933.
6. Schillaci G, Pasqualini L, Verdecchia P, Vaudo G, Marchesi S, et al. (2002) Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J Am Coll Cardiol 39: 2005-2011.
7. Fathi R, Isbel N, Haluska B, Case C, Johnson DW, et al. (2003) Correlates of subclinical left ventricular dysfunction in ESRD. Am J Kidney Dis 41: 1016-1025.
8. Bruch C, Rothenburger M, Gotzmann M, Wichter T, Scheld HH, et al. (2007) Chronic kidney disease in patients with chronic heart failure: impact on intracardiac conduction, diastolic function and prognosis. Int J Cardiol 118: 375-380.
9. Olsen MH, Wachtell K, Bella JN, Palmieri V, Gerdts E, et al. (2004) Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: a LIFE substudy. Journal of Human Hypertension 18: 453-459.
10. Olsson LG, Swedberg K, Cleland JGF, Spark PA, Komajda M, et al. (2007) Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a β-blocker: Results from the Carvedilol Or Metoprolol European Trial (COMET) trial. Eur J Heart Fail 9(8): 795-801.
11. Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, et al. (2002) Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 105: 595-601.
12. Svensson M, Gorst-Rasmussen A, Schmidt EB, Jorgensen KA, Christensen JH, (2009) NT-pro-BNP is an independent predictor of mortality in patients with end-stage renal disease. Clin Nephrol 71(4): 380-6.
13. Paulus WJ, Tscho C, Sanderson JE, Rusconi C, Flachskampf FA, et al. (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28: 2539-2550.
14. Chinese committee on guide of hypertension prevention and treatment (2005) The guidelines for prevention and treatment of hypertension in China (revised edition 2005). Chinese Journal of Hypertension 134(Suppl): 2-41.
15. Sahn D, De Maria A, Kisslo J, Weyman A, (1978) The committee on m-mode standardization of the American Society of Echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072-1083.
16. Devereux R, Koren M, de Simone G, Okin PM, Kligfield P, (1993) Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease. Eur Heart J 14: 8-15.
17. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, et al. (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17: 2937-2944.
18. Nagueh SF, Middleton KJ, Kopelan HA, Zoghbi WA, Quinones MA, (1997) Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll cardiol 30: 1527-1533.
19. Sohn DW, Chai IH, Lee DJ, Kim HC, Kim HS, et al. (1997) Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 30: 474-480.
20. Farias CA, Rodriguez L, Garcia MJ, Sun JP, Klein AL, et al. (1999) Assessment of diastolic function by tissue Doppler echocardiography: comparison with standard transmitral and pulmonary venous flow. J Am Soc Echocardiogr 12: 609-617.
21. London GM, (2002) Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant 17: 29-36.
22. Anil V, Nagesh S, Anavekar, Alessandra M, Thune JJ, et al. (2007) The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT echo study. J Am Coll Cardiol 50: 1238-1245.
23. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB, (2002) Left atrial volume as a morphophysiological expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 90(12): 1284-1289.
24. Osranek M, Seward JB, Buschenreithner B, Bergler-Klein J, Heger M, et al. (2007) Diastolic function assessment in clinical practice: the value of 2-dimensional echocardiography. Am Heart J 154(1): 130-136.
25. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, et al. (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22(2): 107-33.
26. Nishimura RA, Tajik AJ, (1997) Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol 30: 8-18.
27. Slama M, Susic D, Varagic J, Frohlich ED, (2002) Diastolic dysfunction in hypertension. Curr Opin Cardiol 17: 368-373.
28. Otsuka T, Suzuki M, Yoshikawa H, Sugi K, (2009) Left ventricular diastolic dysfunction in the early stage of chronic kidney disease. Journal of Cardiology 54: 199-204.
29. Shaha AM, Lamb CSP, Chenga S, Vermaa Al, Desaia AS, et al. (2011) The relationship between renal impairment and left ventricular structure, function, and ventricular-arterial interaction in hypertension. Journal of Hypertension 29: 1829-1836.
30. Prigent A, (2008) Monitoring Renal Function and Limitations of Renal Function Tests. Semin Nucl Med 38: 32-46.
31. Perrone RD, Steinman TI, Beck GJ, Skibinski CI, Royal HD, et al. (1990) Utility of radioisotopic filtration markers in chronic renal insufficiency: Simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. Am J Kidney Dis 16: 224-235.
32. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, et al. (2009) Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertension 27: 000-000.
33. van Kimmenade RR, Januzzi JL Jr, Bakker JA, FACC, Bakker JA, et al. (2009) Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide: a mechanistic study in hypertensive subjects. J Am Coll Cardiol 53: 884-890.
34. Lainchbury JG, Nicholls MG, Espiner EA, Ikram H, Yandle TG, et al. (1998) Regional plasma levels of cardiac peptides and their response to acute neutral endopeptidase inhibition in man. Clin Sci (Lond) 95: 547-555.
35. Richards AM, Crozier IG, Yandle TG, Espiner EA, Ikram H, et al. (1993) Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease. Br Heart J 69: 414-417.
36. DeFilippi C, van Kimmenade RRJ, Pinto YM, (2008) Amino-terminal pro-B-type natriuretic peptide testing in renal disease. Am J Cardiol 101(suppl): 82A-88A.
37. McCullough PA, Sandberg KR, (2003) Sorting out the evidence on natriuretic peptides. Rev Cardiovasc Med 4: S13-S19.
38. Silverberg D, Wexler D, Blum M, Schwartz D, Iaina A, (2004) The association between congestive heart failure and chronic renal disease. Curr Opin Nephrol Hypertens 13: 163-170.
39. McConnaughey MM, McConnaughey JS, Ingenito AJ, (1999) Practical considerations of the pharmacology of angiotensin receptor blockers. J Clin Pharmacol 39(6): 547-559.
40. Joles JA, Koomans HA, (2004) Causes and consequences of increased sympathetic activity in renal disease. Hypertension 43: 699-706.
41. Esler M, (2000) The sympathetic system and hypertension. Am J Hypertens 13 (6 Pt 2): 99S-105S.
42. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, et al. (2004) Nephropathy in diabetes. Diabetes Care 27 (suppl): s79-s83.
43. De Zeeuw D, Parving H-H, Henning RH, (2006) Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol 17: 2100-2105.
44. Stehouwer CDA, Smulders YM, (2006) Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms. J Am Soc Nephrol 17: 2106-2111.